Search Medical Condition
Please enter condition
Please choose location from dropdown

Midvale, Utah Clinical Trials

A listing of Midvale, Utah clinical trials actively recruiting patient volunteers.

RESULTS

Found (397) clinical trials

A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy

The primary purpose of this study is to evaluate the effects of intrathecal (IT) administration of SHP611 on gross motor function, using the Gross Motor Function Classification in Metachromatic Leukodystrophy (GMFC-MLD) compared with matched historical control data in children with metachromatic leukodystrophy (MLD).

Phase

9.54 miles

Learn More »

Neural and Antidepressant Effects of Propofol

Aim 1: Compare the clinical antidepressant effects of propofol versus placebo. Aim 2: Characterize the effects of propofol on brain function and gene expression.

Phase

9.54 miles

Learn More »

Neural and Antidepressant Effects of Propofol (Phase 2)

Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.

Phase

9.54 miles

Learn More »

Stress Hydrocortisone In Pediatric Septic Shock

Sepsis represents the most common cause of childhood mortality worldwide. In the United States alone, 200 cases of pediatric sepsis are diagnosed each day, with an associated hospital mortality rate of 5-10% and health care expenditures now approaching $5 billion annually. Moreover, nearly one third of children admitted to pediatric ...

Phase

9.54 miles

Learn More »

Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial

Study subjects will be patients in the NICU at one of the participating hospitals at a Neonatal Research Network site. Infants who meet the eligibility criteria will be randomized to either caffeine citrate at 10 mg/kg/dose or placebo (equal volume of all the excipients except for the active ingredient, caffeine ...

Phase

9.54 miles

Learn More »

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

The purpose of this study is to compare the efficacy and safety of ixekizumab to guselkumab in participants with moderate-to-severe plaque psoriasis.

Phase

9.69 miles

Learn More »

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata.

Phase

9.69 miles

Learn More »